Bristol, UK (PRWEB) October 9, 2008
Ascent Scientific (http://www.ascentscientific.com) announced the availability of the first commercial source of VU0155041 - a new research tool that will aid research into Parkinson's Disease. VU0155041 is the latest addition to the Low-Cost Ligand range. It acts as a selective positive allosteric modulator at the mGlu4 glutamate receptor subtype. These receptors are thought to be involved in many neurological conditions including Parkinson's Disease.
Steve Roome PhD, Commercial Director commented, "Ascent Scientific are proud to be the first life science supplier to make this exciting research tool commercially available to the scientific community. As well as making science affordable we are keen to introduce cutting-edge agonists and antagonists to the Low-Cost Ligand range. VU0155041 joins a line up that includes L-thio AP4, cis-PPDA and AMN082 - all cutting-edge tools that we offered to scientists before any other life science vendor."
Iain Sandison, Science Director added, "VU0155041 is available at very high purity (at least 99%). And of course, in keeping with our philosophy, we have introduced it at an affordable price!"
Contact: Steve Roome, Commercial Director +44 (0)1934 624 695
About Ascent Scientific
Ascent Scientific offers a range of high quality receptor ligands and synthetic chemistry services at prices so low that as many researchers as possible will be able to afford them.
The Low-Cost Ligand range includes receptor ligands and signalling tools in research areas such as glutamate, GABA, ion channels, cannabinoids, opioids, 5-HT and more.
The Low-Cost Chemistry Service provides cost-effective custom synthesis of organic molecules, fluorescent labels, standards & references, stable isotope labels, receptor ligands and more.
Ascent Scientific operates out of UK headquarters close to Bristol, and a US Sales & Distribution office in New Jersey.
To request a new catalogue, visit our website http://www.ascentscientific.com.
# # #